Skip to main content

Table 1 Basic characteristics of the subjects

From: Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration

 

RBC (X104/μL)

Platelets (X104/μL)

alb (mg/dL)

HDL-C (mg/dL)

LDL-C (mg/dL)

TG (mg/dL)

ATX (ng/mL)

AA

215.0 ± 9.9*

2.8 ± 0.5

4.4 ± 0.1

54.8 ± 14.6

103.6 ± 35.4

178.5 ± 200.1

1.49 ± 0.39

ET

467.9 ± 101.2

84.8 ± 35.4†

4.2 ± 0.2

56.8 ± 14.4

104.5 ± 40.4

144.7 ± 66.5

0.96 ± 0.13

ITP

472.2 ± 40.1

3.1 ± 1.1

4.1 ± 0.4

57.9 ± 15.7

100.9 ± 25.9

164.2 ± 127.3

0.96 ± 0.13

VWD

423.0 ± 89.9

27.5 ± 6.3

4.4 ± 0.2

28.9 ± 0.4

73.9 ± 59.9

127.7 ± 29.6

0.95 ± 0.12

NHD

436.4 ± 71.8

22.1 ± 8.2

4.1 ± 0.5

40.3 ± 19.0

127.4 ± 53.5

135.7 ± 71.7

0.90 ± 0.07

All

437.3 ± 86.6

31.2 ± 31.1

4.1 ± 0.4

45.1 ± 18.9

116.0 ± 49.6

140.3 ± 78.7

0.95 ± 0.05

  1. Serum samples were collected from subjects with NHD (non-hematological disorders, n=33) and patients with AA (aplastic anemia, n=2), ET (essential thrombocythemia, n=10), ITP (idiopathic thrombocytopenia purpura, n=6), and VWD (von Willebrand diseases, n=3). ATX represents autotaxin. Data were shown as the mean ± SD.
  2. * P<0.01 vs. ET, ITP, NHD, and P<0.05 vs. VWD; †P<0.01 vs. the other groups.